Working… Menu

Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01191996
Recruitment Status : Completed
First Posted : August 31, 2010
Last Update Posted : December 7, 2012
Primorus Clinical Trials
National Multiple Sclerosis Society
Information provided by (Responsible Party):
Innate Immunotherapeutics